{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:16:58Z","timestamp":1765232218916},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T00:00:00Z","timestamp":1424476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10552-015-0539-y","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T08:35:18Z","timestamp":1424421318000},"page":"589-600","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis"],"prefix":"10.1007","volume":"26","author":[{"given":"Xuan-zhang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-xu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-xi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-che","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-wan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-mian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,21]]},"reference":[{"key":"539_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"539_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.11859","volume":"100","author":"SH Giordano","year":"2004","unstructured":"Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN (2004) Is breast cancer survival improving? Cancer 100:44\u201352","journal-title":"Cancer"},{"key":"539_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.22656","volume":"121","author":"L Gallicchio","year":"2007","unstructured":"Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ (2007) Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. Int J Cancer 121:211\u2013215","journal-title":"Int J Cancer"},{"key":"539_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-011-1521-3","volume":"132","author":"HS Kim","year":"2012","unstructured":"Kim HS, Moon HG, Han W et al (2012) COX2 overexpression is a prognostic marker for Stage III breast cancer. Breast Cancer Res Treat 132:51\u201359","journal-title":"Breast Cancer Res Treat"},{"key":"539_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-006-9277-x","volume":"101","author":"CK Blair","year":"2007","unstructured":"Blair CK, Sweeney C, Anderson KE, Folsom AR (2007) NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat 101:191\u2013197","journal-title":"Breast Cancer Res Treat"},{"key":"539_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-014-3099-z","volume":"147","author":"EH Allott","year":"2014","unstructured":"Allott EH, Tse CK, Olshan AF, Carey LA, Moorman PG, Troester MA (2014) Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study. Breast Cancer Res Treat 147:415\u2013421","journal-title":"Breast Cancer Res Treat"},{"key":"539_CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1158\/1055-9965.EPI-11-1012","volume":"21","author":"Y Li","year":"2012","unstructured":"Li Y, Brasky TM, Nie J et al (2012) Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 21:239\u2013242","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"539_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pds.2064","volume":"20","author":"KJ Wernli","year":"2011","unstructured":"Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA (2011) Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf 20:131\u2013137","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"539_CR9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"key":"539_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16","journal-title":"Trials"},{"key":"539_CR11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"539_CR12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"539_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"issue":"Suppl 1","key":"539_CR14","doi-asserted-by":"crossref","first-page":"i82","DOI":"10.1093\/bja\/aet464","volume":"113","author":"P Forget","year":"2014","unstructured":"Forget P, Bentin C, Machiels JP, Berliere M, Coulie PG, De Kock M (2014) Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. Br J Anaesth 113(Suppl 1):i82\u2013i87","journal-title":"Br J Anaesth"},{"issue":"Suppl 3","key":"539_CR15","doi-asserted-by":"crossref","first-page":"S650","DOI":"10.1245\/s10434-013-3136-x","volume":"20","author":"P Forget","year":"2013","unstructured":"Forget P, Machiels JP, Coulie PG et al (2013) Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol 20(Suppl 3):S650\u2013S660","journal-title":"Ann Surg Oncol"},{"key":"539_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2407-14-391","volume":"14","author":"MD Holmes","year":"2014","unstructured":"Holmes MD, Olsson H, Pawitan Y et al (2014) Aspirin intake and breast cancer survival\u2014a nation-wide study using prospectively recorded data in Sweden. BMC Cancer 14:391","journal-title":"BMC Cancer"},{"key":"539_CR17","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/bcr3638","volume":"16","author":"LJ Murray","year":"2014","unstructured":"Murray LJ, Cooper JA, Hughes CM, Powe DG, Cardwell CR (2014) Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case\u2013control study in a breast cancer cohort from the UK Clinical Practice Research Datalink. Breast Cancer Res 16:R34","journal-title":"Breast Cancer Res"},{"key":"539_CR18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjc.2014.264","volume":"111","author":"DM Fraser","year":"2014","unstructured":"Fraser DM, Sullivan FM, Thompson AM, McCowan C (2014) Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer 111:623\u2013627","journal-title":"Br J Cancer"},{"key":"539_CR19","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1158\/0008-5472.CAN-13-3603","volume":"74","author":"LW Bowers","year":"2014","unstructured":"Bowers LW, Maximo IX, Brenner AJ et al (2014) NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin\u2013aromatase interactions. Cancer Res 74:4446\u20134457","journal-title":"Cancer Res"},{"key":"539_CR20","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-13-2679","volume":"74","author":"TI Barron","year":"2014","unstructured":"Barron TI, Flahavan EM, Sharp L, Bennett K, Visvanathan K (2014) Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I\u2013III breast cancer: a nationwide population-based cohort study. Cancer Res 74:4065\u20134077","journal-title":"Cancer Res"},{"key":"539_CR21","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28:1467\u20131472","journal-title":"J Clin Oncol"},{"key":"539_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3816\/CBC.2009.n.038","volume":"9","author":"ME Valsecchi","year":"2009","unstructured":"Valsecchi ME, Pomerantz SC, Jaslow R, Tester W (2009) Reduced risk of bone metastasis for patients with breast cancer who use COX-2 inhibitors. Clin Breast Cancer 9:225\u2013230","journal-title":"Clin Breast Cancer"},{"key":"539_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10552-007-9003-y","volume":"18","author":"ML Kwan","year":"2007","unstructured":"Kwan ML, Habel LA, Slattery ML, Caan B (2007) NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control 18:613\u2013620","journal-title":"Cancer Causes Control"},{"key":"539_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","volume":"83","author":"CR Sharpe","year":"2000","unstructured":"Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA (2000) Nested case\u2013control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 83:112\u2013120","journal-title":"Br J Cancer"},{"key":"539_CR25","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379:1591\u20131601","journal-title":"Lancet"},{"key":"539_CR26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.1376","volume":"93","author":"JG Rozic","year":"2001","unstructured":"Rozic JG, Chakraborty C, Lala PK (2001) Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 93:497\u2013506","journal-title":"Int J Cancer"},{"key":"539_CR27","first-page":"362","volume":"58","author":"H Sheng","year":"1998","unstructured":"Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:362\u2013366","journal-title":"Cancer Res"},{"key":"539_CR28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<371::AID-IJC12>3.0.CO;2-G","volume":"73","author":"PK Lala","year":"1997","unstructured":"Lala PK, Al-Mutter N, Orucevic A (1997) Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H\/HEJ mice. Int J Cancer 73:371\u2013380","journal-title":"Int J Cancer"},{"key":"539_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123\u2013134","journal-title":"Nat Rev Cancer"},{"key":"539_CR30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial\u2013mesenchymal-like transition and promotes metastasis. Cancer Cell 20:576\u2013590","journal-title":"Cancer Cell"},{"key":"539_CR31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1055-9965.EPI-07-2739","volume":"17","author":"AG Hudson","year":"2008","unstructured":"Hudson AG, Gierach GL, Modugno F et al (2008) Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:680\u2013687","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"539_CR32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/aje\/kwm216","volume":"166","author":"VA Kirsh","year":"2007","unstructured":"Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B (2007) Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol 166:709\u2013716","journal-title":"Am J Epidemiol"},{"key":"539_CR33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97:805\u2013812","journal-title":"J Natl Cancer Inst"},{"key":"539_CR34","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291:2433\u20132440","journal-title":"JAMA"},{"key":"539_CR35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3835(97)00387-X","volume":"122","author":"FM Robertson","year":"1998","unstructured":"Robertson FM, Parrett ML, Joarder FS et al (1998) Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett 122:165\u2013175","journal-title":"Cancer Lett"},{"key":"539_CR36","first-page":"3031","volume":"19","author":"GA Alshafie","year":"1999","unstructured":"Alshafie GA, Harris RE, Robertson FM, Parrett ML, Ross M, Abou-Issa H (1999) Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas. Anticancer Res 19:3031\u20133036","journal-title":"Anticancer Res"},{"key":"539_CR37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","volume":"90","author":"D Hwang","year":"1998","unstructured":"Hwang D, Scollard D, Byrne J, Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90:455\u2013460","journal-title":"J Natl Cancer Inst"},{"key":"539_CR38","first-page":"351","volume":"24","author":"HS Jeong","year":"2010","unstructured":"Jeong HS, Kim JH, Choi HY, Lee ER, Cho SG (2010) Induction of cell growth arrest and apoptotic cell death in human breast cancer MCF-7 cells by the COX-1 inhibitor FR122047. Oncol Rep 24:351\u2013356","journal-title":"Oncol Rep"},{"key":"539_CR39","first-page":"1019","volume":"29","author":"DW McFadden","year":"2006","unstructured":"McFadden DW, Riggs DR, Jackson BJ, Cunningham C (2006) Additive effects of Cox-1 and Cox-2 inhibition on breast cancer in vitro. Int J Oncol 29:1019\u20131023","journal-title":"Int J Oncol"},{"key":"539_CR40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsbmb.2010.12.018","volume":"125","author":"LW Chow","year":"2011","unstructured":"Chow LW, Yip AY, Chu WP, Loo WT, Toi M (2011) Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial. J Steroid Biochem Mol Biol 125:112\u2013119","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 2","key":"539_CR41","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1016\/S0753-3322(05)80051-4","volume":"59","author":"LW Chow","year":"2005","unstructured":"Chow LW, Cheng CW, Wong JL, Toi M (2005) Serum lipid profiles in patients receiving endocrine treatment for breast cancer\u2014the results from the celecoxib anti-aromatase neoadjuvant (CAAN) trial. Biomed Pharmacother 59(Suppl 2):S302\u2013S305","journal-title":"Biomed Pharmacother"},{"key":"539_CR42","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/bcr3409","volume":"15","author":"RD Brandao","year":"2013","unstructured":"Brandao RD, Veeck J, Van de Vijver KK et al (2013) A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer. Breast Cancer Res 15:R29","journal-title":"Breast Cancer Res"},{"key":"539_CR43","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.2012.44.7805","volume":"31","author":"PE Goss","year":"2013","unstructured":"Goss PE, Ingle JN, Pritchard KI et al (2013) Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27\u2014a randomized controlled phase III trial. J Clin Oncol 31:1398\u20131404","journal-title":"J Clin Oncol"},{"key":"539_CR44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA et al (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071\u20131080","journal-title":"N Engl J Med"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-015-0539-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0539-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:06:37Z","timestamp":1559235997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-015-0539-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,21]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1007\/s10552-015-0539-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,21]]}}}